Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Red Light Holland Corp. C.TRIP

Alternate Symbol(s):  TRUFF

Red Light Holland Corp. is a Canada-based company. The Company is engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal recreational market within the Netherlands. Its subsidiaries include RLH Netherlands BV, RLH Farms BV, Red Light Holland (Subco 1) Inc., SR... see more

CSE:TRIP - Post Discussion

Red Light Holland Corp. > Red Light Holland and PharmAla to Collaborate
View:
Post by Betteryear2 on Feb 09, 2024 12:21pm

Red Light Holland and PharmAla to Collaborate

  • PharmAla will consult on GMP Drug Product and Regulatory Development for Red Light Holland

Toronto, Ontario--(Newsfile Corp. - February 9, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws, is pleased to announce it has entered into a consulting relationship with PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) ("PharmAla"), to consult on the development of clinical-grade Psilocybin Drug Product extracted from Red Light Holland's naturally occurring psilocybin truffles.

Red Light Holland and PharmAla to Collaborate on Medical Psilocybin Development (newsfilecorp.com)

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities